Why Is Lyme Disease Harder to Diagnose Without a Rash?
Lyme disease can occur without a recognized rash
Without erythema migrans, diagnosis may take longer
A 2026 study found a significant difference in diagnostic delay
Why is Lyme disease harder to diagnose without a rash? An erythema migrans (EM) rash can provide an important early clue that points clinicians toward Lyme disease. When that clue is absent, symptoms such as fever, fatigue, muscle pain, headache, nerve symptoms, or other nonspecific complaints may have many possible explanations.
A 2026 national surveillance study from Japan provides measurable evidence of this diagnostic problem. Patients with Lyme disease who did not have erythema migrans experienced a significantly longer interval between their first medical visit and diagnosis than patients who had the rash.1
The difference was substantial: the median time from the first medical visit to diagnosis was 41 days in patients without EM compared with 28 days in patients with EM.1
The finding is particularly notable because patients were not simply waiting at home. Across the study population, the median time from symptom onset to the first medical visit was only four days. Yet the median time from onset to diagnosis was 28.5 days.1
This suggests that an important part of the delay occurred after patients had already entered the healthcare system.
For more on how early Lyme disease may present when the expected rash is absent or overlooked, see first symptoms of Lyme disease and why the rash may be missed.
What Did the 2026 Lyme Disease Study Find?
Goto and colleagues analyzed Lyme disease cases reported through Japan’s National Epidemiological Surveillance of Infectious Diseases. The retrospective descriptive study examined national surveillance data covering fiscal years 2006 through 2023.1
Researchers identified 265 reported Lyme disease cases. Of these, 216 were considered domestically acquired, 43 were imported, and six had an unknown place of infection.1
The median age was 53 years, and 62% of patients were male. Most infections occurred between May and September, and approximately 75% of domestically acquired infections were estimated to have occurred in Hokkaido.1
The study also found a statistically significant upward trend in the number of reported domestic Lyme disease cases between 2006 and 2023. However, the authors cautioned that the reason for this increase was unclear and that increased awareness of tick-borne diseases may have contributed to greater recognition and reporting.1
Patients Without a Lyme Rash Waited Longer for a Diagnosis
The diagnostic-delay finding is one of the most clinically important results of the study.
Among patients with sufficient timing information, the median intervals were:1
- 4 days from symptom onset to the first medical visit
- 28.5 days from symptom onset to diagnosis
- 20 days from the first medical visit to diagnosis
When researchers separated patients according to whether erythema migrans was present, the difference became clearer.
- Patients with erythema migrans: median 28 days from first visit to diagnosis
- Patients without erythema migrans: median 41 days from first visit to diagnosis
The difference was statistically significant (P = 0.007).1
These findings do not mean that every patient without a rash will experience a 41-day diagnostic delay. The numbers come from a Japanese national surveillance system with its own testing procedures, healthcare structure, tick species, and circulating Borrelia species.
They do, however, provide evidence for a broader clinical problem: when the most recognizable sign of Lyme disease is missing, diagnosis may become more difficult.
Why Does a Lyme Rash Make Diagnosis Easier?
Erythema migrans is one of the few manifestations of Lyme disease that can immediately narrow the diagnostic possibilities.
Without a recognizable rash, early Lyme disease may resemble a viral illness or many other conditions. Patients may report fever, fatigue, headache, muscle aches, joint pain, or other nonspecific symptoms that do not immediately point toward a tick-borne infection.
A tick bite may not provide the missing clue either. Many patients never notice the tick responsible for their infection.
In the Japanese surveillance study, erythema migrans was reported in approximately 70% of symptomatic cases. Fever was reported in 45%, myositis or myalgia in 26%, neurological symptoms in 20%, and arthritis in 7%.1
When several nonspecific symptoms occur without the rash, clinicians may understandably need to consider a much broader differential diagnosis.
Earlier Studies Also Found That the Initial Presentation Matters
The 2026 findings are consistent with earlier Lyme disease research.
In a 2023 study of 271 patients with early Lyme disease in the United States, Rebman and colleagues compared patients who first noticed erythema migrans with patients whose viral-like symptoms appeared first.2
Patients who noticed EM first had a shorter duration of illness before treatment. After adjustment for other factors, having EM as the initial presentation was associated with a 22% decrease in time to treatment compared with having symptoms first.2
An earlier community case series published by Aucott and colleagues in 2009 also illustrated the diagnostic difficulty created when erythema migrans is absent or not recognized. Among patients diagnosed with early Lyme disease who did not present with EM, more than half had previously been misdiagnosed.3
Together, these studies suggest that the way Lyme disease first presents can influence how quickly clinicians recognize it.
A Rash Can Also Be Present but Overlooked
The diagnostic problem is not limited to patients who truly never develop erythema migrans.
An EM rash may be uniformly red rather than resembling the stereotypical bull’s-eye. It may occur on the scalp, back, groin, behind the knee, or another location that is difficult for the patient to see. It may also be mistaken for an insect bite, bruise, allergic reaction, cellulitis, or other skin condition.
Therefore, the clinically relevant distinction is often whether a recognized and correctly identified erythema migrans rash is present—not simply whether any skin lesion ever occurred.
This is one reason Lyme disease misdiagnosis can occur even when patients seek medical attention relatively early.
Neurological Lyme Disease May Be Especially Difficult to Recognize
The Japanese study also found neurological symptoms in 20% of reported cases.1
Among patients for whom more detailed neurological information was available, reported manifestations included peripheral nerve symptoms, meningitis, and facial nerve palsy.1
The authors noted that Lyme neuroborreliosis may be underdetected in Japan and recommended considering Lyme disease when evaluating otherwise unexplained neurological symptoms in affected areas.1
This is clinically important because neurological presentations may move the diagnostic evaluation toward disorders involving the brain, spinal cord, cranial nerves, or peripheral nerves rather than immediately toward an infectious disease.
Again, the presence or absence of a rash may influence how quickly Lyme disease enters the differential diagnosis.
Testing Can Add Another Layer of Difficulty
The Japanese investigators suggested that limited clinical awareness and restricted access to Lyme disease testing likely contributed to diagnostic delays in their healthcare system.1
Testing challenges differ between countries, but another problem applies more broadly: antibody-based Lyme disease tests may be less helpful very early in infection because the immune response takes time to develop.
This means that a patient without a recognizable rash may face two simultaneous diagnostic problems: fewer distinctive clinical clues and laboratory testing that may not yet provide a clear answer.
For a closer discussion of this testing window, see why early Lyme disease tests can be negative.
What the Japanese Study Does Not Prove
The 2026 study is useful, but its findings should not be generalized beyond what the data support.
It was a retrospective descriptive analysis of cases reported through Japan’s national surveillance system. Reported cases required laboratory confirmation, and testing was available through a limited number of public health laboratories.1
Japan also has a different Lyme disease ecology from North America. The authors identify Borrelia bavariensis as the main causative organism in Japan and Ixodes persulcatus as the primary vector, whereas Borrelia burgdorferi and blacklegged ticks such as Ixodes scapularis predominate in much of the United States.1
The surveillance system recorded symptoms and outcomes at the time cases were reported but did not require follow-up, meaning later manifestations could have been missed. The authors also noted that Lyme disease is probably underreported in the surveillance system.1
Most importantly, the study demonstrates an association between absence of EM and longer diagnostic time within this surveillance population. It does not establish that the missing rash was the only reason for each patient’s delay.
Frequently Asked Questions
Can you have Lyme disease without a rash?
Yes. A recognized erythema migrans rash is an important sign of early Lyme disease, but some patients do not develop one, do not see it, or do not recognize it as a Lyme rash. Lyme disease should not be excluded solely because an EM rash was not noticed.
Why is Lyme disease harder to diagnose without a rash?
Without erythema migrans, symptoms such as fever, fatigue, headache, muscle pain, joint pain, or neurological complaints can resemble many other illnesses. The absence of a distinctive clinical clue can broaden the differential diagnosis and delay consideration of Lyme disease.
How much longer did diagnosis take when the rash was absent?
In the 2026 Japanese surveillance study, the median interval from the first medical visit to diagnosis was 41 days in reported Lyme disease cases without erythema migrans compared with 28 days in cases with erythema migrans. These figures describe that study population and should not be assumed to apply to every patient or healthcare system.
Does an absent rash mean a Lyme blood test will be positive?
No. The presence or absence of a rash does not determine whether an antibody test will be positive. Early in infection, antibodies may not yet have reached detectable levels, so test timing remains important.
Can neurological Lyme disease occur without a rash?
Yes. Neurological manifestations can occur even when an erythema migrans rash was not recognized. In the 2026 Japanese surveillance study, neurological symptoms were reported in 20% of cases overall, including peripheral nerve symptoms, meningitis, and facial nerve palsy.
Clinical Takeaway
A visible erythema migrans rash can make early Lyme disease easier to recognize, but its absence does not exclude infection. The 2026 Japanese surveillance study offers unusually clear evidence of the diagnostic difference: patients without EM had a median 41-day interval from their first medical visit to diagnosis compared with 28 days among patients with EM.
The study also shows why diagnostic delay cannot always be explained by patients waiting too long to seek care. Across the population studied, patients first presented for medical attention a median of only four days after symptom onset.
When Lyme disease presents without a recognizable rash, clinicians may need to rely more heavily on the complete pattern of symptoms, possible tick exposure, geography, timing, examination findings, and appropriately interpreted laboratory testing.
Related Articles
These articles explore other reasons Lyme disease may be difficult to recognize early:
Can You Get Sick From a Tick Bite Without Developing a Rash?
Can You Have Lyme Disease Without Seeing a Tick Bite?
Can You Have a Lyme Rash but Still Test Negative?
References
- Goto K, Kato H, Kanesaki M, Nakamura N, Orime A, Ikenoue C, Sato K, Shimada T, Takizawa Y, Takahashi T, Kamigaki T, Kawabata H, Sunagawa T. Epidemiology of Lyme disease, a growing tick-borne disease of concern, in Japan from May 2013 to March 2024: a descriptive study. IJID Regions. 2026;19:100919.
- Rebman AW, Yang T, Yoon I, Powell D, Geller SA, Aucott JN. Initial presentation and time to treatment in early Lyme disease. American Journal of Tropical Medicine and Hygiene. 2023;108(4):734-737.
- Aucott J, Morrison C, Munoz B, Rowe PC, Schwarzwalder A, West SK. Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infectious Diseases. 2009;9:79.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
